Mr. Christopher J. Stevo CFA

Senior Vice President & Chief Investor Relations Officer

Mr. David M. Denton

Chief Financial Officer & Executive Vice President

Mr. Frank A. D'Amelio

Dr. Albert  Bourla D.V.M., DVM, Ph.D.

Chairman & Chief Executive Officer

Dr. Mikael  Dolsten M.D., Ph.D.

Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical

Ms. Angela  Hwang

Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.

Mr. Douglas M. Lankler

Executive Vice President & Gen. Counsel

Ms. Lidia L. Fonseca

Executive Vice President and Chief Digital & Technology Officer

Mr. John D. Young

Advisor

Ms. Jennifer B. Damico

Senior Vice President, Controller & Principal Accounting Officer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed.

How Pfizer's $43 billion acquisition of Seagen could impact the biotech industry in Seattle

Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions

Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma. Pfizer CEO Dr. Albert Bourla speaks to David Westin.

Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion

CNBC's Meg Tirrell joins 'Power Lunch' to discuss Pfizer's acquisition of Seagen, the reasoning behind the $43 billion biotech deal, and more.

Pfizer offers $43 billion to buy cancer drugmaker Seagen

Pfizer CEO Albert Bourla said it will deliver Seagen's cancer therapy to the world at a scale that hasn't been seen before with its $43 billion acquisition.

Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal

Pfizer Agrees to Buy Seagen for $43 Billion

Pfizer Overpays for Seagen, but Who’s Counting

Pfizer Rolls the Dice on Seagen in $43 Billion Deal

Pfizer Is in Early-Stage Talks to Acquire Seagen

Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer Expects Drop in Revenue as Vaccine Demand Wanes

Pfizer to Pull Back on Rare Disease Research

Drugmakers Spent Freely in 2022 to Protect Revenue

Pfizer Lays Out Plan to Grow Revenue Ahead of $17 Billion Hit 

Pfizer, BioNTech Announce FDA Fast Track for Covid, Flu Vaccine

FDA Authorizes Moderna, Pfizer Bivalent Vaccines for Kids Under 5

Joe Rosenberg on Why Alphabet and Pfizer Look Like Buys

Pfizer Raises Revenue Outlook on Higher-Than-Expected Covid Vaccine Sales

RSV Vaccine Protects Babies From Severe Infections, Pfizer Study Finds

Drugmakers Fight Over Lucrative Pneumonia Vaccines

GSK, Pfizer Duel Over RSV Vaccine Is Heating Up

Moderna Booster Shortage Sees Fewer Appointments

Pfizer Gets FDA 'Breakthrough' Designation for Group B Strep Vaccine

How Pfizer-BioNTech Modified Covid-19 Vaccines for Fall Boosters

Covid-19 Booster Shots Targeting Omicron Authorized

FDA Authorizes Omicron Booster Shots

Covid Booster Rollout to Precede Human-Trial Data 

Moderna Sues Pfizer and BioNTech Over mRNA Patents

Pfizer Jumps Ahead in Crowded Race for Lucrative RSV Vaccine

Fall Booster Rollout Looks Set for Early September

Covid-19 Booster Campaign Expected to Launch Next Month 

Pfizer Says 3-Dose Covid-19 Vaccine for Children is 73% Effective

Pfizer, BioNTech Seek FDA Approval for Updated Covid-19 Vaccine

There's Progress, and Lots of Questions, on Covid Booster Shots

Pfizer CEO Bourla Has Covid With Mild Symptoms

Pfizer in Advanced Talks to Buy Global Blood Therapeutics 

Pfizer in Talks to Buy Global Blood Therapeutics: Report

Pfizer's CEO Is Confident 2 Covid Boosters Will Be Ready 

Pfizer Sales Climb Again on Covid-19 Products

Drugmakers Hope New Heart Drugs Boost Sales, Revive Market

Giant Manager Buys Up Apple, Nvidia, Corning, and Pfizer Stock

Pfizer Brought Us a Covid Vaccine and Paxlovid. Here’s What’s Next.

FDA Fully Approves Pfizer’s Covid-19 Vaccine for Adolescents 

The BA.5 Omicron Wave Is Rising. What It Means for Your Next Booster.

Pfizer Raises Covid Vaccine Price 27%. What It Means for the Stock.

Pfizer Asks FDA to Fully Approve Its Covid-19 Pill 

U.S. Agrees to Pay $3.2 Billion for More Pfizer Covid Vaccines

FDA Advisers Sign Off on Omicron Booster 

Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response

CDC Recommends Covid-19 Vaccines for Young Children

FDA Authorizes Covid-19 Vaccines for Young Children

FDA Advisers Endorse Pfizer, Moderna Covid-19 Vaccines in Young Children

Pfizer's Covid Vaccine Safe and Effective in Children Under 5, FDA Says

Pfizer Covid Vaccine Works Safely in Young Children

Pfizer Asks FDA to Authorize Its Covid-19 Vaccine for Children Under 5 

Pfizer to Sell Vaccines, Drugs at Low Prices to Poorer Countries 

Pfizer's New Drug Yields Encouraging Treatment Data

Covid-19 Vaccine and Drug Sales, Once Booming, Plateau 

Three Doses of Pfizer’s Covid-19 Vaccine 80% Effective in Young Children, Company Says

Stocks Are Ready for a Bounce Higher After S&P 500 Rallies Out of Bear Market

Pfizer Covid Booster for Kids Aged 5 to 11 Cleared by CDC

CDC Recommends Covid-19 Boosters for 5- to 11-Year-Olds

FDA Clears Pfizer Covid Booster for Kids Aged 5 to 11

Pfizer’s Covid-19 Booster Cleared for 5- to 11-Year-Olds

Pfizer Is Spending $11.6 Bln on Biohaven. Its Plans Point to a Lot More M&A.

Pfizer to Buy Rest of Biohaven for $11.6 Billion

Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

Pfizer Sales Soar on Covid-19 Vaccine Sales

Pfizer Earnings and Revenue Soundly Beat Estimates

Pfizer’s Covid Pill Failed Study Testing Its Preventive Use

Pfizer to Buy ReViral for Up to $525 Million

Pfizer Just Made a Small Acquisition. It May Be More Important Than It Looks.

BioNTech's Earnings Top Estimates. It Plans a Buyback and Special Dividend.

FDA, CDC Endorse Second Covid-19 Booster Shot for Adults 50 and Over

Pfizer, Unicef Strike Covid-19 Pill Deal

Moderna Seeks FDA Clearance for Second Covid-19 Booster Shot in All Adults

Pfizer to Continue to Supply Medicines to Russia, but Will End Planned Investments

Vaccine Stocks Rally on Booster Chatter and a China Covid Surge

Merck’s Covid-19 Pill Heavily Used So Far Despite Concerns 

Pfizer Steps Ahead of Glaxo in Race for Maternal RSV Vaccine

Pfizer’s Covid-19 Vaccine Protected Kids During Omicron Wave, CDC Study Finds

FDA Eyes Second Covid-19 Booster Shot

Lower Omicron Efficacy Led to FDA Delay on Pfizer Shot in Young Kids

FDA to Take More Time Reviewing Pfizer’s Covid-19 Vaccine in Young Children

Pfizer Forecasts $54 Billion in 2022 Sales From Covid Vaccine, Treatment 

Peloton, Pfizer, Meta, General Motors: What to Watch in the Stock Market Today

Pfizer Stock Drops After Earnings. Guidance Fell Short of Estimates.

Booster Doses Reduce Hospitalizations From Omicron, CDC Says

SoFi, Bakkt, Bank of America, Cisco: What to Watch When the Stock Market Opens Today

Pfizer’s New Covid-19 Pill Works Against Omicron in Lab 

GlaxoSmithKline Rejects Unilever Offer for its Consumer Health Unit

Moderna, Novavax, and Other Vaccine Stocks Get Whacked by Supreme Court's Vaccine Decision

Novak Djokovic Reacts to Australian Court Win, FedEx Warns Omicron Hitting Staff

FDA Shortens Waiting Period for Moderna Covid Booster Shot to 5 Months

Covid Roundup: CDC Recommends Boosters for Kids 12 and Up, Hospitalizations for Children Rise

Powered by AI

Pfizer Inc.

38.97